Tissue-Specific shRNA Delivery: A Novel Approach for Gene Therapy in Cancer

REFERENCES

• Matzke M.A., Birchler J.A. RNAi-mediated pathways in the nucleus. Nat Rev Genet. 2005; 6: 24–35
   PubMed Web of Science ®Google Scholar
• Napoli C., Lemieux C., Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 1990; 2: 279–289
   PubMed Web of Science ®Google Scholar
• Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811
   PubMed Web of Science ®Google Scholar
• Kennerdell J.R., Carthew R.W. Heritable gene silencing in Drosophila using double-stranded RNA. Nat Biotechnol. 2000; 18: 896–898
   PubMed Web of Science ®Google Scholar
• Aigner A. Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. J. Biomed. Biotechnol. 2006; 71659
   PubMedGoogle Scholar
• Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006; 441: 537–541
   PubMed Web of Science ®Google Scholar
• Turley E.A. The Biology of Hyaluronan. , et al. J.Wiley & Sons, Ltd., Chichester, U.K. 1989; 121
   Google Scholar
• Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004; 4: 528–539
   PubMed Web of Science ®Google Scholar
• Ghatak S., Misra S., Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem. 2002; 77: 38013–38020
   Google Scholar
• Knudson C.B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB. J. 1993; 7: 1233–1241
   PubMed Web of Science ®Google Scholar
• Entwistle J., Hall C.L., Turley E.A. HA receptors: regulators of signalling to the cytoskeleton. J. Cell. Biochem. 1996; 61: 569–577
   PubMed Web of Science ®Google Scholar
• Campbell P., Laurent T.C., Roden L. Assay and properties of N-acetylglucosamine-6-phosphate deacetylase from rat liver. Anal. Biochem. 1987; 166: 134–141
   PubMed Web of Science ®Google Scholar
• Hua Q., Knudson C.B., Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell. Sci. 1993; 106: 365–375
   PubMed Web of Science ®Google Scholar
• Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 2003; 4: 33–45
   PubMed Web of Science ®Google Scholar
• Nakazawa H., Yoshihara S., Kudo D., Morohashi H., Kakizaki I., Kon A., et al. 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells. Cancer Chemother. Pharmacol. 2006; 57: 165–170
   PubMedGoogle Scholar
• Ghatak S., Misra S., Toole B.P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol. Chem. 2005; 280: 8875–8883
   PubMed Web of Science ®Google Scholar
• Misra S., Toole B.P., Ghatak S. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J. Biol. Chem. 2006; 281: 34936–34941
   PubMed Web of Science ®Google Scholar
• Mike S., Harrison C., Coles B., Staffurth J., Wilt T.J., Mason M.D. Chemotherapy for hormone-refractory prostate cancer. Cochrane Database Syst. Rev. 2006; CD005247
   Google Scholar
• Welsh C.F., Zhu D., Bourguignon L.Y. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J. Cell. Physiol. 1995; 164: 605–612
   PubMed Web of Science ®Google Scholar
• Omara-Opyene A.L., Qiu J., Shah G.V., Iczkowski K.A. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab. Invest. 2004; 84: 894–907
   PubMed Web of Science ®Google Scholar
• Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 2001; 1: 11–21
   PubMed Web of Science ®Google Scholar
• Dohadwala M., Luo J., Zhu L., Lin Y., Dougherty G.J., Sharma S., et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J. Biol. Chem. 2001; 276: 20809–20812
   PubMed Web of Science ®Google Scholar
• Reeder J.A., Gotley D.C., Walsh M.D., Fawcett J., Antalis T.M. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res. 1998; 58: 3719–3726
   PubMed Web of Science ®Google Scholar
• Ruponen M., Honkakoski P., Tammi M., Urtti A. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J. Gene. Med. 2004; 6: 405–414
   PubMed Web of Science ®Google Scholar
• Ruponen M., Ronkko S., Honkakoski P., Pelkonen J., Tammi M., Urtti A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem. 2001; 276: 33875–33880
   PubMed Web of Science ®Google Scholar
• Eliaz R.E., Szoka F.C., Jr. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 2001; 61: 2592–2601
   PubMed Web of Science ®Google Scholar
• Haapala J., Arokoski J.P., Ronkko S., Agren U., Kosma V.M., Lohmander L.S., et al. Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs. Ann. Rheum. Dis. 2001; 60: 55–60
   PubMed Web of Science ®Google Scholar
• Ventura A., Meissner A., Dillon C.P., McManus M., Sharp P.A., Van Parijs L., et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 2004; 101: 10380–10385
   PubMed Web of Science ®Google Scholar
• Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322–324
   PubMed Web of Science ®Google Scholar